DETAILED ACTION
Notice of Pre-AIA or AIA Status
1. The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
2. This action is in response to the papers filed August 13, 2026. Applicant’s remarks and amendments have been fully and carefully considered but are not found to be sufficient to put the application in condition for allowance. Any new grounds of rejection presented in this Office Action are necessitated by Applicant's amendments. Any rejections or objections not reiterated herein have been withdrawn. This action is made FINAL.
Applicant’s election without traverse of Group III in the reply filed on May 8, 2026 is reiterated for the record.
Claims 1-4 and 6-11 are currently pending.
Claims 1-3, 9, and 11 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to non-elected subject matter (a non-elected invention), there being no allowable generic or linking claim. Election was made without traverse in the reply filed on May 8, 2026.
Claim Rejections - 35 USC § 112
3. The following is a quotation of 35 U.S.C. 112(b):
(b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention.
The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph:
The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention.
Claims 4, 6-8, and 10 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention.
Claims 4 and 6-8 are rejected over the recitation of the phrase “the fatty acid trait of strains” in claim 4 step S2. There is insufficient antecedent basis for this limitation in the claim because although the claim previously refers to a “total fatty acid content index” it does not refer to a “fatty acid trait of strains”.
Claims 4 and 6-8 are rejected over the recitation of the phrase “the allowable barcode combinations” in claim 4 step S2. There is insufficient antecedent basis for this limitation in the claim because although the claim previously refers to a “specific verified combination of DNA barcodes” it does not refer to “allowable barcode combinations”.
Claims 4 and 6-8 are rejected over the recitation of the phrase “the test sample” in claim 4 step S3. There is insufficient antecedent basis for this limitation in the claim because although the claim previously refers to a “Floccularia luteovirens sample” it does not refer to a “tested sample”.
Claims 4 and 6-8 are rejected over the recitation of the phrase “the fragment length” in claim 4 step S3. There is insufficient antecedent basis for this limitation in the claim.
Claims 4 and 6-10 are rejected over the recitation of the phrase “the electrophoresis map” in claim 4 step S3. There is insufficient antecedent basis for this limitation in the claim.
Claims 4 and 6-8 are rejected over the recitation of the phrase “the tested Floccularia luteovirens sample” in claim 4 step S3. There is insufficient antecedent basis for this limitation in the claim because although the claim previously refers to a “Floccularia luteovirens sample” it does not refer to a “tested Floccularia luteovirens sample”.
4. It is noted for the record that the prior art fails to teach or suggest all of the claimed limitations. In particular, the prior art does not teach or suggest the specific primers (SEQ ID NOs: 1, 2, 5, 6, 10, 11, 15, and 16) required by the claims. Further the prior art does not teach or suggest the specific primer pairs (SEQ ID NOs: 1 and 2, SEQ ID NOs: 5 and 6, SEQ ID NOs: 10 and 11, and SEQ ID NOs: 15 and 16) as required by the claims.
The closest prior arts are discussed below:
Jing (Food Research International 48 2012 155-163) teaches determination of fatty acids from mushrooms, including Armillaria luteo-virens (also known as Floccularia luteovirens), using high performance liquid chromatography with fluorescence detection and online mass spectrometry (abstract). The reference does not teach determination of fatty acid from Floccularia luteovirens using PCR and capillary electrophoresis as required by the claims.
Xing (Biochemical Systematics and Ecology 56 2014 1-7) teaches analysis of SSR markers in Armillaria luteo-virens (also known as Floccularia luteovirens) by PCR. However Xing does not teach the specific SSR makers recited in the claims and does not teach a correlation between any SSR marker and fatty acid content.
5. Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a).
A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any extension fee pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the date of this final action.
Any inquiry concerning this communication or earlier communications from the examiner should be directed to AMANDA HANEY whose telephone number is (571)272-8668. The examiner can normally be reached Monday-Friday, 8:15am-4:45pm EST.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Wu-Cheng Shen can be reached at 571-272-3157. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/AMANDA HANEY/Primary Examiner, Art Unit 1682